September 15: The Week in Cancer News
New report charts progress in cancer care, and immediate access to test results can lead to confusion.
Progress Against Cancer
New report charts progress in cancer care, and immediate access to test results can lead to confusion.
The FDA Project Renewal initiative has updated the approved indications for temozolomide chemotherapy in anaplastic astrocytoma. The U.S. Food and Drug Administration (FDA) has approved updated labeling of temozolomide (Temodar), including new and revised...
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors of the 10 AACR journals. This month’s selections include a drug that can help overcome...
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and more news selected by the editors of Cancer Today.
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids could be leveraged to reveal the presence of cancer and monitor its course has become...
“Administrative tasks” for cancer patients are linked to delayed or missed doctor visits, lab tests, prescriptions, and other services. Attempts by cancer patients to get more information about costs and health insurance coverage may...
Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
Study finds association between lorazepam use and poorer cancer outcomes, and weight-loss surgery linked to lower cancer risk in women.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More